The nicotinic acetylcholine (ACh) receptor (nAChR) plays a crucial role in excitatory neurotransmission and is an important target for drugs and insecticides. Diverse nAChR subtypes with various subunit combinations confer differential selectivity for nicotinic drugs. We investigated the subtype selectivity of nAChR agonists by comparing two ACh-binding proteins (AChBPs) as structural surrogates with distinct pharmacological profiles [i.e., Lymnaea stagnalis (Ls) AChBP of low neonicotinoid and high nicotinoid sensitivities and Aplysia californica (Ac) AChBP of high neonicotinoid sensitivity] mimicking vertebrate and insect nAChR subtypes, respectively. The structural basis of subtype selectivity was examined here by photoaffinity labeling. Two azidoneonicotinoid probes in the Ls-AChBP surprisingly modified two distinct and distant subunit interface sites: loop F Y164 of the complementary or (؊)-face subunit and loop C Y192 of the principal or (؉)-face subunit, whereas three azidonicotinoid probes derivatized only Y192. Both the neonicotinoid and nicotinoid probes labeled Ac-AChBP at only one position at the interface between loop C Y195 and loop E M116. These findings were used to establish structural models of the two AChBP subtypes. In the Ac-AChBP, the neonicotinoids and nicotinoids are nestled in similar bound conformations. Intriguingly, for the Ls-AChBP, the neonicotinoids have two bound conformations that are inverted relative to each other, whereas nicotinoids appear buried in only one conserved conformation as seen for the Ac-AChBP subtype. Accordingly, the subtype selectivity is based on two disparate bound conformations of nicotinic agonists, thereby establishing an atypical concept for neonicotinoid versus nicotinoid selectivity between insect and vertebrate nAChRs.acetylcholine-binding protein ͉ imidacloprid ͉ neonicotinoids ͉ nicotinic receptor ͉ photoaffinity labeling T he nicotinic acetylcholine (ACh) receptor (nAChR) is critically important in synaptic neurotransmission and the target of potential therapeutic agents for neurological dysfunction and of major neonicotinoid insecticides for crop protection and animal health. The drug-binding sites are localized at subunit interfaces of the nAChR pentameric structure. Specific vertebrate and insect subunit combinations make up diverse nAChR subtypes that differ in pharmacological profiles (1, 2). Highly subtype-selective nicotinic agents are required for development of therapeutics and insecticides. A family of peptide antagonists, the ␣-conotoxins, serve as important probes for studying structural determinants of subtype selectivity (3-5). However, the molecular mechanism of selectivity for small agonist molecules is not resolved because most of the key amino acids in the nAChR-binding pocket are conserved in all of the receptor subtypes and species and the binding region for antagonists extends over a large interfacial surface. Understanding drugnAChR interactions was greatly facilitated by the discovery and crystallization of mollusk homopentamer...